Texas MPN Workshop 2020 | MPNs as a disease spectrum: are genomics the key to one’s destiny?

Raajit Rampal, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, gives his thoughts on classifying myeloproliferative neoplasms (MPNs) into further sub-divisions, the role of genomics and where we go from here. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).